Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The investigators aim to evaluate the effect of curcumin and virgin coconut oil extract supplementation on people with type 2 DM, including blood glucose, HbA1c levels, inflammation, body weight and insulin resistance evaluation
The investigators give Kurcosmart supplementation aside from diabetes standard treatment to evaluate its benefits on people with type 2 DM, considering its effect on controlling fasting and prandial blood glucose, reducing HbA1c level, controlling inflammation degree; and repairing insulin resistance
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control Group | No Intervention | There is no additional intervention other than subject's standard diabetes treatment | |
| Interventional Group | Experimental | This group will received additional supplementation of curcumin and virgin coconut oil aside from their standard treatment |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Curcumin and virgin coconut oil extract (KurCo Smart) | Dietary Supplement | we give 2 tablets of curcumin and virgin coconut oil extract thrice a day for 30 days and evaluate the result |
| Measure | Description | Time Frame |
|---|---|---|
| Blood glucose | Subject's fasting and prandial blood glucose | Change of Blood glucose at 1 months |
| Inflammation degree | Subject's high sensitivity C-reactive protein level | Change of hs-CRP at 1 Months |
| insulin resistance | Subject's HOMA IR | Change of HOMA IR at 1 Months |
| HbA1c | Subject's glycated haemoglobin level | Change of HbA1C at 1 Months |
| Measure | Description | Time Frame |
|---|---|---|
| Body Mass Index | Subject's height and body weight | Change of BMI at 1 Months |
| Blood Pressure | Subject's blood pressure | Change fof blood prssure at 1 Months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Nurhasan Agung Prabowo, MD | Contact | 6282328010430 | dr.Nurhasan21@staff.uns.ac.id |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| UNS Hospital | Sukoharjo | Central Java | 57161 | Indonesia |
Individual participant data will be restricted for this study purpose only
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| D007333 | Insulin Resistance |
| D007249 | Inflammation |
| D001835 | Body Weight |
| D003920 | Diabetes Mellitus |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D003474 | Curcumin |
| ID | Term |
|---|---|
| D036381 | Diarylheptanoids |
| D006536 | Heptanes |
| D000473 | Alkanes |
| D006839 | Hydrocarbons, Acyclic |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D006946 | Hyperinsulinism |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012816 | Signs and Symptoms |
| D006838 |
| Hydrocarbons |
| D009930 | Organic Chemicals |
| D002396 | Catechols |
| D010636 | Phenols |
| D001555 | Benzene Derivatives |
| D006841 | Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |